drugset / Trial / NCT04296695
Biktarvy in Treatment-Naïve Late Presenters With HIV-1 Infection
RandomizedParallel-groupOpen-labelTreatment
Summary
The efficacy and safety of Biktarvy in Treatment-Naïve Late Presenters with HIV-1 Infection
Timeline
- Start
- 2021-07-14
- Primary completion
- 2022-12-13
- Completion
- 2025-06-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | B/F/TAF | Unknown | — | — |
| Comparator | EFV | Unknown | 400 mg | — |
| Comparator | Lamivudine | Other / unclassified | 300 mg | — |
| Comparator | TDF | Unknown | 300 mg | — |